As of now, Latvia reports a research & development by business enterprise, pharmaceutical industry in current ppp $ of 13.07 million, signifying an increase of 2.45 million (23.0%) from 2020.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Latvia
No matching regions
Similar regions to Latvia
More indicators for Latvia
Government R&D in security as % of government support
1.61%
-1.01%
(2021)
R&D financed by rest of the world in local currency
756.98M
+64.87M
(2021)
Government R&D financed by rest of the world in local currency
221.75M
+55.75M
(2021)
Business R&D financed by rest of the world in local currency
201.76M
+46.65M
(2021)
Non-profit R&D growth rate
-100%
0%
(2006)
Latvia Business R&D pharmaceutical in current PPP $ between 2008 and 2021
| Period | Value | Change |
|---|---|---|
| 2021 | 13.07M | +2.45M |
| 2020 | 10.63M | +0.71M |
| 2019 | 9.92M | +0.65M |
| 2018 | 9.27M | +0.72M |
| 2017 | 8.54M | +2.87M |
| 2016 | 5.68M | +0.25M |
| 2015 | 5.43M | -0.00M |
| 2014 | 5.43M | -5.79M |
| 2013 | 11.22M | +1.54M |
| 2012 | 9.68M | +2.38M |
| 2010 | 7.30M | -1.10M |
| 2008 | 8.41M |